We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$194M
Cap. Flow
+$40.5M
Cap. Flow %
2.24%
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74

Top Buys

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$32.5M
2
AMAT icon
Applied Materials
AMAT
+$26.5M
3
AAPL icon
Apple
AAPL
+$13.7M
4
MSFT icon
Microsoft
MSFT
+$11.9M
5
NVDA icon
NVIDIA
NVDA
+$9.49M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$28.3M
2
BEKE icon
KE Holdings
BEKE
+$13.2M
3
TSM icon
TSMC
TSM
+$13.2M
4
ASX icon
ASE Group
ASX
+$7.59M
5
IQ icon
iQIYI
IQ
+$6.13M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.73%
2 Technology 31.74%
3 Communication Services 9.52%
4 Healthcare 5.08%
5 Financials 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMT icon
151
American Tower
AMT
$82.1B
$678K 0.04%
3,487
+2,038
+141% +$381K
CSX icon
152
CSX Corp
CSX
$95B
$657K 0.04%
19,629
-4,290
-18% -$146K
CAMT icon
153
Camtek
CAMT
$6.33B
$655K 0.04%
5,227
-289
-5% -$27.6K
IDXX icon
154
Idexx Laboratories
IDXX
$43.7B
$649K 0.04%
1,333
+12
+0.9% +$6.02K
CEG icon
155
Constellation Energy
CEG
$98.1B
$634K 0.04%
3,166
+45
+1% +$9.18K
RH icon
156
RH
RH
$2.83B
$630K 0.03%
2,579
BPMC
157
DELISTED
Blueprint Medicines
BPMC
$622K 0.03%
5,768
+1,073
+23% +$107K
MDGL icon
158
Madrigal Pharmaceuticals
MDGL
$12.3B
$620K 0.03%
2,212
+514
+30% +$122K
DXCM icon
159
DexCom
DXCM
$34.3B
$618K 0.03%
5,455
+331
+6% +$41.8K
PYPL icon
160
PayPal
PYPL
$45.9B
$611K 0.03%
10,524
-24
-0.2% -$1.53K
CDW icon
161
CDW
CDW
$18.5B
$605K 0.03%
2,703
+454
+20% +$105K
CRSP icon
162
CRISPR Therapeutics
CRSP
$5.58B
$599K 0.03%
11,088
+5,597
+102% +$324K
ON icon
163
ON Semiconductor
ON
$28.3B
$594K 0.03%
8,663
-4,370
-34% -$307K
CPRT icon
164
Copart
CPRT
$30.5B
$568K 0.03%
10,482
+1,118
+12% +$61K
ANSS
165
DELISTED
Ansys
ANSS
$565K 0.03%
1,758
+306
+21% +$100K
APLS
166
DELISTED
Apellis Pharmaceuticals
APLS
$564K 0.03%
14,696
+7,664
+109% +$347K
TOL icon
167
Toll Brothers
TOL
$13.5B
$548K 0.03%
4,758
+2,576
+118% +$312K
MRVL icon
168
Marvell Technology
MRVL
$195B
$545K 0.03%
7,803
+572
+8% +$40.1K
PCAR icon
169
PACCAR
PCAR
$66B
$543K 0.03%
5,272
+99
+2% +$10.9K
TPR icon
170
Tapestry
TPR
$25B
$537K 0.03%
12,544
TEL icon
171
TE Connectivity
TEL
$58.7B
$535K 0.03%
3,556
+975
+38% +$143K
ROIV icon
172
Roivant Sciences
ROIV
$25.1B
$533K 0.03%
50,381
+9,805
+24% +$107K
GEHC icon
173
GE HealthCare
GEHC
$32.4B
$528K 0.03%
6,782
+430
+7% +$35.1K
TJX icon
174
TJX Companies
TJX
$149B
$521K 0.03%
+4,733
New +$477K
CCL icon
175
Carnival Corporation Ltd
CCL
$33.9B
$506K 0.03%
27,038

Similar funds

E Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, E Fund Management held 392 positions worth $1.81B, up 12% from $1.61B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

E Fund Management's Q2 2024 filing shows 24 new, 176 increased, 102 reduced and 74 closed positions. Its largest new stake was Futu Holdings: 480,000 shares worth $31.5M. The largest sale was Advanced Micro Devices, an estimated $28.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q2 2024 buy was Futu Holdings: 480,000 shares worth $31.5M.
  • E Fund Management added most to Applied Materials in Q2 2024, an estimated $26.5M increase.
  • E Fund Management's biggest Q2 2024 reduction was Advanced Micro Devices, cutting an estimated $28.3M.
  • E Fund Management fully exited Yum China in Q2 2024, selling an estimated $5.17M.
  • E Fund Management's ten largest holdings make up 64% of its $1.81B portfolio in Q2 2024.
  • E Fund Management opened 24 new positions and closed 74 in Q2 2024.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.81B.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.